Fang, Zhenhao
Peng, Lei
Filler, Renata
Suzuki, Kazushi
McNamara, Andrew
Lin, Qianqian
Renauer, Paul A.
Yang, Luojia
Menasche, Bridget http://orcid.org/0000-0003-3520-2422
Sanchez, Angie
Ren, Ping
Xiong, Qiancheng http://orcid.org/0000-0002-9897-7391
Strine, Madison
Clark, Paul
Lin, Chenxiang http://orcid.org/0000-0001-7041-1946
Ko, Albert I. http://orcid.org/0000-0001-9023-2339
Grubaugh, Nathan D. http://orcid.org/0000-0003-2031-1933
Wilen, Craig B. http://orcid.org/0000-0003-2495-9403
Chen, Sidi http://orcid.org/0000-0002-3819-5005
Funding for this research was provided by:
U.S. Department of Defense (W81XWH-21-1-0019)
Article History
Received: 1 March 2022
Accepted: 24 May 2022
First Online: 6 June 2022
Competing interests
: A patent application has been filed by Yale University related to the data described here (inventors: S.C., L.P., Z.F., and P.R.). Yale University has committed to rapidly executable nonexclusive royalty-free licenses to intellectual property rights for the purpose of making and distributing products to prevent, diagnose, and treat COVID-19 infection during the pandemic and for a short period thereafter. S.C. is a scientific Founder of EvolveImmune Tx and Cellinfinity Bio, unrelated to this study. The remaining authors declare no competing interests.